CNS pipeline · person
Andreas Krebs
Vice Chair of the Board of Directors of Definium Therapeutics, serving as an independent director since September 2021 and as independent Vice Chair since December 2021. An international pharma executive and entrepreneur; he leads Longfield Invest, formerly President and Executive Board Member at Wyeth, and chaired the Supervisory Board of Merz Pharma (2010-2019).
- 1 company
Courtesy Definium Therapeutics
Current roles
- Definium Therapeutics, Inc.Vice Chair of the Board of Directors · Board
Appears with
People sharing a company with Andreas.
- Brandi Roberts · Definium Therapeutics, Inc.
- Carol A. Vallone · Definium Therapeutics, Inc.
- Daniel R. Karlin · Definium Therapeutics, Inc.
- Gregg Pratt · Definium Therapeutics, Inc.
- Mark Sullivan · Definium Therapeutics, Inc.
- Matt Wiley · Definium Therapeutics, Inc.
- Maurizio Fava · Definium Therapeutics, Inc.
- Robert Barrow · Definium Therapeutics, Inc.
- Robert C. Malenka · Definium Therapeutics, Inc.
- Roger Adsett · Definium Therapeutics, Inc.
- Stephanie Fagan · Definium Therapeutics, Inc.
- Suzanne Bruhn · Definium Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.